IL1B and cancer: Devazepide (10 mg/kg) was administered orally once a day from day 7 to 14 after transplantation, and gene expression of ephrin B1 and the Eph B1 receptor in L4-5 DRGs and the amount of IL-1β protein in the cancer-inoculated region were then measured.